Trial Profile
RANDOMIZED DOUBLE-BLIND, MULTIPLE DOSE, PLACEBO-CONTROLLED STUDY TO DETERMINE THE INSULIN SENSITIZING EFFECT OF BGP-15 IN PATIENTS WITH INSULIN RESISTANCE
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2011
Price :
$35
*
At a glance
- Drugs BGP 15 (Primary)
- Indications Insulin resistance
- Focus Pharmacodynamics
- 07 Aug 2009 New trial record.